DE69620724T2 - Ophthalmische Formulierung auf Natriumhyaluronatbasis zur Verwendung in der Augenchirurgie - Google Patents

Ophthalmische Formulierung auf Natriumhyaluronatbasis zur Verwendung in der Augenchirurgie

Info

Publication number
DE69620724T2
DE69620724T2 DE69620724T DE69620724T DE69620724T2 DE 69620724 T2 DE69620724 T2 DE 69620724T2 DE 69620724 T DE69620724 T DE 69620724T DE 69620724 T DE69620724 T DE 69620724T DE 69620724 T2 DE69620724 T2 DE 69620724T2
Authority
DE
Germany
Prior art keywords
sodium hyaluronate
eye surgery
ophthalmic formulation
based ophthalmic
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69620724T
Other languages
English (en)
Other versions
DE69620724D1 (de
Inventor
Rene-Pierre Buenter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemedica SA
Original Assignee
Chemedica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemedica SA filed Critical Chemedica SA
Publication of DE69620724D1 publication Critical patent/DE69620724D1/de
Application granted granted Critical
Publication of DE69620724T2 publication Critical patent/DE69620724T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
DE69620724T 1995-12-22 1996-12-19 Ophthalmische Formulierung auf Natriumhyaluronatbasis zur Verwendung in der Augenchirurgie Expired - Lifetime DE69620724T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI002744A IT1277707B1 (it) 1995-12-22 1995-12-22 Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare

Publications (2)

Publication Number Publication Date
DE69620724D1 DE69620724D1 (de) 2002-05-23
DE69620724T2 true DE69620724T2 (de) 2002-11-21

Family

ID=11372809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69620724T Expired - Lifetime DE69620724T2 (de) 1995-12-22 1996-12-19 Ophthalmische Formulierung auf Natriumhyaluronatbasis zur Verwendung in der Augenchirurgie

Country Status (10)

Country Link
US (1) US5880107A (de)
EP (1) EP0781547B1 (de)
JP (1) JP4146910B2 (de)
AT (1) ATE216221T1 (de)
CA (1) CA2193543C (de)
DE (1) DE69620724T2 (de)
DK (1) DK0781547T3 (de)
ES (1) ES2175020T3 (de)
IT (1) IT1277707B1 (de)
PT (1) PT781547E (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541460B2 (en) 1996-08-07 2003-04-01 George D. Petito Method for use of hyaluronic acid in wound management
US6368585B1 (en) * 1997-03-25 2002-04-09 Pharmacia Ab Opthalmic compositions and methods
US20030138499A1 (en) * 1998-12-17 2003-07-24 Shah Mandar V. Stable surgical irrigating solutions
US6533769B2 (en) * 2001-05-03 2003-03-18 Holmen Joergen Method for use in cataract surgery
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
ITMI20020557A1 (it) * 2002-03-15 2003-09-15 Acraf Uso di un sale dell'acido l-ascorbico per preparare una composizione farmaceutica per uso topico oftalmico capace di migliorare il livello d
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20050215516A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
US20060073184A1 (en) * 2004-09-29 2006-04-06 Bausch & Lomb Inc. Viscoelastic composition, methods of use and packaging device with anti-oxidant
US20080131522A1 (en) * 2006-10-03 2008-06-05 Qing Liu Use of placental biomaterial for ocular surgery
US20080293637A1 (en) * 2007-05-23 2008-11-27 Allergan, Inc. Cross-linked collagen and uses thereof
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) * 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
JP5670196B2 (ja) 2007-11-16 2015-02-18 バイセプト セラピューティクス、インク． 紫斑を治療する組成物および方法
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394784B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
EP2229180A1 (de) * 2007-12-27 2010-09-22 D.M.G. Italia Srl Zusammensetzung mit superoxid-dismutase und carboxy-methyl-beta-1,3-glucan
US8357795B2 (en) * 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
ES2829971T3 (es) 2008-09-02 2021-06-02 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos
US20100104654A1 (en) * 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
JP4885245B2 (ja) * 2009-01-15 2012-02-29 日本航空電子工業株式会社 Ｒｄコンバータ及び角度検出装置
WO2011075430A1 (en) * 2009-12-14 2011-06-23 University Of Massachusetts Methods of inhibiting cataracts and presbyopia
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US20110171310A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
KR101764451B1 (ko) 2010-03-12 2017-08-02 알러간 인더스트리 에스에이에스 피부 상태 개선을 위한 히알루론안 폴리머 및 만니톨을 포함하는 유체 조성물
PL3078388T3 (pl) 2010-03-22 2019-08-30 Allergan, Inc. Usieciowane hydrożele do powiększania tkanek miękkich
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
KR102312056B1 (ko) 2011-06-03 2021-10-12 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
NZ708821A (en) * 2012-12-19 2020-03-27 Novartis Ag Lfa-1 inhibitor formulations
AT514540A1 (de) * 2013-06-18 2015-01-15 Apomedica Pharmazeutische Produkte Gmbh Ophthalmische Zusammensetzung
ES2933549T3 (es) * 2013-07-10 2023-02-10 Matrix Biology Inst Composiciones de hialuronano con alta elasticidad y usos de las mismas
WO2015125921A1 (ja) * 2014-02-20 2015-08-27 わかもと製薬株式会社 保存効力を有する医薬用水性組成物
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
CA2995977A1 (en) * 2015-08-18 2017-02-23 Astellas Institute For Regenerative Medicine Clinical formulations
EP3842047A1 (de) 2015-09-24 2021-06-30 Matrix Biology Institute Hyaluronanzusammensetzungen mit hoher elastizität und verfahren zur verwendung davon
PL3525799T3 (pl) * 2016-10-14 2022-05-16 i.com medical GmbH Sposób ustanawiania, przywracania i utrzymywania homeostazy powierzchni oka
WO2019103932A1 (en) * 2017-11-22 2019-05-31 Bausch & Lomb Incorporated Ophthalmic viscoelastic compositions
CN113354757B (zh) * 2021-06-26 2022-04-08 上海加新生物科技有限公司 一种小分子透明质酸钠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US4886786A (en) * 1985-08-01 1989-12-12 Lindstrom Richard L Additive for irrigation solution or surgical solution
IL80298A (en) 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
US4920104A (en) * 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
US5204331A (en) * 1990-06-29 1993-04-20 Santen Pharmaceutical Co., Ltd. Composition for debridement of retained lens materials
WO1994007505A1 (en) * 1991-07-03 1994-04-14 Norpharmco Inc. Use of hyaluronic acid and forms to prevent arterial restenosis
JPH06107538A (ja) * 1992-03-31 1994-04-19 Shiseido Co Ltd 角膜移植用眼球保存液
JPH05310580A (ja) * 1992-04-30 1993-11-22 Shiseido Co Ltd 眼内灌流用液剤

Also Published As

Publication number Publication date
IT1277707B1 (it) 1997-11-11
EP0781547B1 (de) 2002-04-17
DK0781547T3 (da) 2002-08-12
ITMI952744A0 (de) 1995-12-22
CA2193543C (en) 2006-02-21
JPH09216826A (ja) 1997-08-19
EP0781547A1 (de) 1997-07-02
ES2175020T3 (es) 2002-11-16
JP4146910B2 (ja) 2008-09-10
CA2193543A1 (en) 1997-06-23
US5880107A (en) 1999-03-09
ITMI952744A1 (it) 1997-06-22
ATE216221T1 (de) 2002-05-15
PT781547E (pt) 2002-09-30
DE69620724D1 (de) 2002-05-23

Similar Documents

Publication Publication Date Title
DE69620724T2 (de) Ophthalmische Formulierung auf Natriumhyaluronatbasis zur Verwendung in der Augenchirurgie
DE69420196D1 (de) Ophtalmologische Vorrichtung für den vorderen Augenbereich
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
SE8403090D0 (sv) Gel for anvendning som glaskroppssubstitut
ATE482675T1 (de) Optisches implantat für die hornhaut
IE893270L (en) Ophthalmic staple and instruments for implementing use
AU5318394A (en) Eye stabilizing mechanism for use in ophthalmic laser surgery
AU4128901A (en) Colored visco-elastic composition
GR1000611B (el) Μεθοδος για την παρασκευη οφθαλμικων συνθεσεων κυκλοσπορινης.
AU5446299A (en) Medicinal compositions for treating eye diseases
DE69943067D1 (de) Verwendung von dreidimensionalen Prothesen, die Hyaluronsäurederivate enthalten
ES2052893T3 (es) Preparado de n-acetil-glucosamina para administracion por via bucal.
DE69105349T2 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
AU3658793A (en) Bimodal molecular weight hyaluronate formulations and methods for using same
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
FR2670670B1 (fr) Instrument de chirurgie corneenne.
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
WO2002036096A3 (en) Non-aspirating transitional viscoelastics for use in surgery
IT9048173A0 (it) Apparecchiatura per il posizionamento e l'azionamento di strumenti chirurgici, in particolare per chirurgia corneale refrattiva, in particolare chirurgia refrattiva lamellare.
ATE202922T1 (de) Ophthalmische cromolyn-gelzubereitung
ATE158719T1 (de) Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung
UA29334A (uk) Очні краплі
IT9041580A0 (it) Cannula per operazioni microchirurgiche in particolare per la chirurgia oftalmica

Legal Events

Date Code Title Description
8364 No opposition during term of opposition